MedTrace Logo

Clinical Assessment of Patients With High Bone Mass Due to Mutation in Lrp5

NCT01199094 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2010-09-10

No results posted yet for this study

Summary

The aim of the study is to describe patients with a high bone mass phenotype due to a mutation in the low density lipoprotein l receptor 5 gene (LRP5) and compare them with age and sex matched controls. Moreover, bone density and microarchitecture as well as markers of bone metabolism are evaluated

Conditions

  • Osteopetrosis

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Kim Brixen, Professor · Odense University Hospital

Eligibility

Min Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-04-30
Completion
2010-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01199094 on ClinicalTrials.gov